Middleton & Co. Inc. MA Sells 753 Shares of The Procter & Gamble Company (NYSE:PG)

Middleton & Co. Inc. MA lessened its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 4.6% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,683 shares of the company’s stock after selling 753 shares during the period. Middleton & Co. Inc. MA’s holdings in Procter & Gamble were worth $2,586,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Alera Investment Advisors LLC lifted its position in shares of Procter & Gamble by 1.2% during the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the last quarter. Hudson Value Partners LLC lifted its holdings in Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after purchasing an additional 60 shares during the last quarter. Fiduciary Alliance LLC boosted its position in Procter & Gamble by 2.8% during the second quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after purchasing an additional 61 shares during the period. LCM Capital Management Inc increased its stake in shares of Procter & Gamble by 1.1% in the first quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock worth $925,000 after purchasing an additional 63 shares in the last quarter. Finally, Home Federal Bank of Tennessee raised its position in shares of Procter & Gamble by 0.3% in the second quarter. Home Federal Bank of Tennessee now owns 23,318 shares of the company’s stock valued at $3,846,000 after purchasing an additional 63 shares during the period. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Trading Down 1.1 %

Shares of PG stock opened at $173.91 on Thursday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The firm has a market cap of $410.45 billion, a P/E ratio of 28.42, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The business has a 50-day moving average price of $169.94 and a two-hundred day moving average price of $165.55. The Procter & Gamble Company has a 12-month low of $141.45 and a 12-month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s quarterly revenue was down .1% on a year-over-year basis. During the same period in the previous year, the business posted $1.37 EPS. Equities analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were given a $1.0065 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.31%. Procter & Gamble’s payout ratio is currently 65.85%.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 375,553 shares of company stock worth $63,829,141. Insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on PG shares. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Royal Bank of Canada boosted their price objective on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 31st. TD Cowen began coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Stifel Nicolaus upped their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research report on Monday, July 22nd. Finally, Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Seven research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $175.79.

View Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.